Figure 1From: CD40 deficiency mitigates Alzheimer's disease pathology in transgenic mouse modelsPercentages of 4G8-positive β-amyloid plaques (mean ± s.e.m) by area in (a) Tg APPsw/CD40 def. mice versus Tg APPsw mice and in (b) Tg PSAPP/CD40 def. mice versus Tg PSAPP mice at 22 to 24 months of age calculated by quantitative image analysis. Post hoc comparison between groups are indicated by the marked bars (* p < 0.05 ; ** p < 0.01 ; *** p < 0.001).Back to article page